Complement system and age-related macular degeneration: drugs and challenges.

ABSTRACT: Age-related macular degeneration (AMD) is directly attributable to vision loss, posing significant pressure on public health. AMD is recognized to be a multi-factorial disease and among them, complement system is under heated discussion in recent years. In this review, we start with an overview of complement pathways involved in AMD and their therapies correspondingly. Finally, we discuss the development of the therapeutics existed now. Also, we enclose a list of drugs undergoing clinical trials.

SUBMITTER: Wu J 

PROVIDER: S-EPMC6650090 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature